Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Apogee Therapeutics, Inc. Income Statement Banner

Apogee Therapeutics, Inc. Income Statement

APGE Stock Analysis

Page title

Section title

Breakdown
2022
2023
Total Revenue
0.0000.000
Cost of Revenue
0.0000.000
Gross Profit
0.0000.000
Operating Expense
30.727M93.003M
Operating Income
-30.727m-93.003m
Other Income Expense
0.0000.000
Total Other Income Expense
-9.058m9.018M
Pretax Income
-39.785m-83.985m
Tax Provision
-33.520k-93.003k
Net Income
-39.785m-83.985m
Basic EPS
-0.790-1.660
Diluted EPS
-0.790-1.660
Basic Average Shares
50.674M50.656M
Diluted Average Shares
50.674M50.656M
Total Expenses
30.727M93.003M
Interest Income
92.000K9.018M
Interest Expense
9.150M0.000
EBITDA
-30.727m-93.003m
Depreciation & Amortization
33.520M93.003M